Literature DB >> 22365093

Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature.

Simin Dashti-Khavidaki1, Foroud Shahbazi, Hossein Khalili, Mahboob Lessan-Pezeshki.   

Abstract

Drug-induced nephrotoxicity (DIN) accounts for up to sixty percent of hospital acquired acute kidney injury. Several efforts have been made to reduce drug-induced renal damage; however, DIN remains a matter of concern, with substantial impact on patients and the health system. Silymarin is a drug that has been used for many years in alternate and modern medicine for treating hepatic diseases. Its antioxidant, anti-inflammatory and anti-apoptotic effects make it an interesting herbal medicine, and these properties have implicated this compound as a potential renoprotective agent. Based on the findings from animal studies, this review concluded that silymarin might exert significant protective or ameliorative effects against drug-induced kidney disease, especially against cisplatin-induced renal damage. Whether the protective administration of silymarin could be an effective clinical pharmacological strategy to prevent DIN is a question that remains to be answered in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365093     DOI: 10.18433/j3f88s

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  16 in total

Review 1.  Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Authors:  Atefeh Jafari; Hossein Khalili; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2014-06-25       Impact factor: 2.953

2.  The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.

Authors:  Khaled Khazim; Yves Gorin; Rita Cassia Cavaglieri; Hanna E Abboud; Paolo Fanti
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

Review 3.  Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.

Authors:  Abhishek Gour; Diksha Manhas; Swarnendu Bag; Bapi Gorain; Utpal Nandi
Journal:  Phytother Res       Date:  2021-03-30       Impact factor: 6.388

Review 4.  Silymarin and diabetic nephropathy.

Authors:  Mahmoud Rafieian-Kopaie; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2012-01-01

5.  Inhibition of ERK1/2 by silymarin in mouse mesangial cells.

Authors:  Cha Kyung Youn; Sung Il Cho; Min Young Lee; Young Jin Jeon; Seog Ki Lee
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

Review 6.  An Overview on Renoprotective Effects of Thymoquinone.

Authors:  Hanieh Shaterzadeh-Yazdi; Mohammad-Foad Noorbakhsh; Saeed Samarghandian; Tahereh Farkhondeh
Journal:  Kidney Dis (Basel)       Date:  2018-02-14

7.  The effect of silymarin on liver enzymes and antioxidant status in trauma patients in the intensive care unit: a randomized double blinded placebo-controlled clinical trial.

Authors:  Ehsan Mirzaei; Golnar Sabetian; Mansoor Masjedi; Reza Heidari; Mahtabalsadat Mirjalili; Amirreza Dehghanian; Afsaneh Vazin
Journal:  Clin Exp Hepatol       Date:  2021-06-22

8.  Silymarin for the Prevention of Contrast-Induced Nephropathy: A Placebo-Controlled Clinical Trial.

Authors:  Zohreh Sedighifard; Farshad Roghani; Peyman Bidram; Samaneh Aalami Harandi; Safieh Molavi
Journal:  Int J Prev Med       Date:  2016-01-22

9.  Role of garlic extract and silymarin compared to dimercaptosuccinic acid (DMSA) in treatment of lead induced nephropathy in adult male albino rats.

Authors:  Iman A El-Khishin; Yara Mohamed Medhat El-Fakharany; Omaima I Abdel Hamid
Journal:  Toxicol Rep       Date:  2015-05-08

10.  Nephroprotective Effect of Zingerone against CCl4-Induced Renal Toxicity in Swiss Albino Mice: Molecular Mechanism.

Authors:  Mohammed M Safhi
Journal:  Oxid Med Cell Longev       Date:  2018-01-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.